CRIS Current Research Information System

PALLADINI, ARIANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.638
EU - Europa 1.743
AS - Asia 793
AF - Africa 154
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 5.333
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.616
GB - Regno Unito 427
IT - Italia 408
CN - Cina 407
VN - Vietnam 242
DE - Germania 227
SE - Svezia 197
UA - Ucraina 85
IN - India 81
CH - Svizzera 75
IE - Irlanda 73
RU - Federazione Russa 63
FR - Francia 55
CI - Costa d'Avorio 53
TG - Togo 45
ZA - Sudafrica 37
EE - Estonia 35
BG - Bulgaria 32
BE - Belgio 22
CA - Canada 22
SG - Singapore 20
JO - Giordania 13
RO - Romania 12
FI - Finlandia 11
EG - Egitto 6
JP - Giappone 6
NG - Nigeria 6
NL - Olanda 6
SC - Seychelles 6
HK - Hong Kong 4
HR - Croazia 4
DK - Danimarca 3
IR - Iran 3
PL - Polonia 3
SA - Arabia Saudita 3
BD - Bangladesh 2
CL - Cile 2
GR - Grecia 2
KR - Corea 2
TR - Turchia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AT - Austria 1
BR - Brasile 1
ES - Italia 1
ID - Indonesia 1
IL - Israele 1
IQ - Iraq 1
LB - Libano 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
SN - Senegal 1
TH - Thailandia 1
Totale 5.333
Salva come PNG Salva come JPEG
Città #
Fairfield 392
Southend 370
Chandler 328
Ashburn 220
Woodbridge 172
Wilmington 170
Houston 168
Shanghai 165
Ann Arbor 158
Seattle 143
Dong Ket 132
Cambridge 130
Princeton 93
Bologna 80
Dublin 73
Bern 70
Abidjan 53
Jacksonville 49
Lomé 45
Westminster 39
Beijing 36
Bremen 36
Padova 33
Nanjing 32
Sofia 32
Berlin 31
Redmond 26
Redwood City 24
Brussels 22
Jinan 22
Saint Petersburg 21
Milan 18
Guangzhou 17
San Diego 17
Turin 17
Ottawa 16
Tianjin 16
Shenyang 15
Hebei 14
Singapore 14
Amman 13
Changsha 13
Des Moines 13
Jiaxing 12
Nanchang 12
Boardman 11
Mülheim 10
Helsinki 9
New York 8
Bühl 7
Chieti 7
Crocetta 7
Kerpen 7
London 7
Zhengzhou 7
Buffalo 6
Crotone 6
Dearborn 6
Delhi 6
Los Angeles 6
Mahé 6
Moscow 6
Phoenix 6
Vicenza 6
Abeokuta 5
Haikou 5
Lanzhou 5
Medford 5
Ningbo 5
Taizhou 5
Hong Kong 4
Leawood 4
Portici 4
Reggio Nell'emilia 4
Taiyuan 4
Verona 4
Washington 4
Amsterdam 3
Bagni 3
Carrara 3
Castenaso 3
Falls Church 3
Hangzhou 3
Muizenberg 3
Nærum 3
Olalla 3
Parma 3
Rome 3
Toronto 3
Ankara 2
Bochum 2
Boydton 2
Catania 2
Catanzaro 2
Civate 2
Cordenons 2
Cupertino 2
Dallas 2
Den Haag 2
Florence 2
Totale 3.822
Salva come PNG Salva come JPEG
Nome #
IFN-γ and CD38 in Hyperprogressive Cancer Development 281
Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograft 225
Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations 209
A multi-DNA preventive vaccine for p53/Neu driven cancer syndrome 200
Cancer Vaccines Co-Targeting HER2/Neu and IGF1R 165
Preclinical therapy of disseminated HER-2+ ovarian and breast carcinomas with a HER-2-retargeted oncolytic herpesvirus. 149
Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy 145
Endothelin-3 production by human rhabdomyosarcoma: A possible new marker with a paracrine role. 141
Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma. 138
Systemic delivery of HER2-retargeted oncolytic-HSV by mesenchymal stromal cells protects from lung and brain metastases 138
ImmunoGrid: Towards agent-based simulations of the human immune system at a natural scale 137
Virus-like particle display of HER2 induces potent anti-cancer responses 136
Cancer immunoprevention: from mice to early clinical trials 135
Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model 129
Antimetastatic activity of a preventive cancer vaccine. 128
Multiorgan Metastasis of Human HER-2+ Breast Cancer in Rag2−/−;Il2rg−/− Mice and Treatment with PI3K Inhibitor 125
Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER-2. 124
Activated d16HER2 Homodimers and SRC Kinase Mediate Optimal Efficacy for Trastuzumab. 124
HER-2/neu tolerant and non-tolerant mice for fine assessment of antimetastatic potency of dendritic cell-tumor cell hybrid vaccines 122
Human responses against HER-2-positive cancer cells in human immune system-engrafted mice. 120
Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasis 117
Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis 116
Modeling the competition between lung metastases and the immune system using agents. 115
In silico modeling and in vivo efficacy of cancer preventive vaccinations 113
Tumor suppressor genes promote rhabdomyosarcoma progression in p53 heterozygous, HER-2/neu transgenic mice. 109
Inhibition of prostate carcinogenesis by combined active immunoprophylaxis. 108
Expression of a functional CCR7 chemokine receptor inhibits the post-intravasation steps of metastasis in malignant murine mammary cancer cells 107
OX40 triggering concomitant to IL12-engineered cell vaccine hampers the immunoprevention of HER2/neu-driven mammary carcinogenesis 105
High metastatic efficiency of human sarcoma cells in Rag2/gamma c double knockout mice provides a powerful test system for antimetastatic targeted therapy 104
HER2 isoforms co-expression differently tunes mammary tumor phenotypes affecting onset, vasculature and therapeutic response 103
Opposing control of rhabdomyosarcoma growth and differentiation by myogenin and interleukin 4. 103
Expression of connective tissue growth factor (CTGF/CCN2) in a mouse model of rhabdomyosarcomagenesis. 102
Evaluation of metastatic burden and recovery of human metastatic cells from a mouse model 98
The mechanisms of PD-L1 regulation in non-small-cell lung cancer (NSCLC): Which are the involved players? 96
Computational models as novel tools for cancer vaccines. 95
Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomas 93
Translational immunomics of cancer prevention. 92
Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer 92
Proteomic and PROTEOMEX profiling of mammary cancer progression in a HER-2/neu oncogene-driven animal model system 86
Mathematical and computational models in tumor immunology 83
ImmunoGrid, an integrative environment for large-scale simulation of the immune system for vaccine discovery, design, and optimization 77
Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression 73
ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1- rearranged NSCLC 69
Predictive models in tumor immunology. 57
HER Tyrosine Kinase Family and Rhabdomyosarcoma: Role in Onset and Targeted Therapy 56
Prevention and Therapy of Metastatic HER-2+ Mammary Carcinoma with a Human Candidate HER-2 Virus-like Particle Vaccine 40
Genomic Landscape, Clinical Features and Outcomes of Non-Small Cell Lung Cancer Patients Harboring BRAF Alterations of Distinct Functional Classes 34
Immune checkpoint inhibitors in lung tumors with rare histologies and other thoracic malignancies 2
Totale 5.516
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.659
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.659
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.367 157 33 19 81 149 126 177 192 193 108 66 66
2020/2021976 142 43 28 55 34 40 63 131 90 44 43 263
2021/20221.005 102 47 83 38 99 70 29 54 52 66 223 142
2022/20231.261 132 154 67 183 75 99 44 66 180 54 103 104
2023/2024490 25 45 22 32 29 50 25 209 7 19 11 16
2024/202550 50 0 0 0 0 0 0 0 0 0 0 0
Totale 5.516